COVID-19 Impact on Getinge AB's Revenue and Operations (Medical Devices)

Summary

Getinge AB (Getinge) is a medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care, headquartered in Sweden with global manufacturing and sales reach. Getinge's product range include surgical tables, lights, ventilators and anaesthesia equipment, heart-lung machines with accompanying disposables, equipment and instruments for cardiac surgery, vascular surgery devices, cardiac assist devices, patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipment, and documentation systems and accessories. The report, COVID-19 Impact on Getinge AB's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Getinge AB is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Getinge AB is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

• Getinge’s overall revenue has seen a very strong growth in 2020 which is attributable to its increased purchasing for ICU ventilators and extracorporeal membrane oxygenation across hospitals (ECMO) therapy products across all regions.
• Getinge has seen an outstanding performance in the last quarters which is the result of strong growth in acute care therapies during the pandemic.Getinge was particularly exposed to downturns in its surgical workflows, life sciences segments as a result of postponed elective healthcare but expects order intakes to increase sequentially.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Getinge AB -

• It provides insights on Getinge AB's exposure to the regions and businesses impacted by the COVID-19 outbreak.
• It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

• An overview of how Getinge AB will be affected by the COVID-19 pandemic.